Epizyme
Epizyme is a biopharmaceutical company focused on the discovery and development of epigenetic medicines to treat cancer and other disease
3
Funding Rounds
$309.5m
Money raised
Overview
Epizyme is a biopharmaceutical company focused on the discovery and development of epigenetic medicines to treat cancer and other disease
-
Website:
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| vi* ri**** | - | - | |
| Sa** Na**** | - | - | - |
| gr*** bo*** | - | - | |
| Ri F. Po** | - | - | |
| Ke*** Co**** | - | - | twitter instagram |
| Be** Se*** | - | - | - |
| Th**** Da**** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Epizyme has raised a total of $309.5m in funding over 3 rounds.
Key Insights:
- Epizyme , November 2019: $270m
- Epizyme funding round, June 2011: $7.5m
- Epizyme Series B round: $32m
Epizyme , November 2019
$270m
Epizyme funding round, June 2011
$7.5m
Epizyme Series B round
$32m
Industries
Epizyme is active in the following industries: